In recent years, the prevalence of obesity and cancer have been rising. Since this poses a serious threat to human health, the relationship between the two has attracted much attention. This study examined whether fat mass and obesity-associated (
FTO
) genes are linked, taking into account a Genome-wide Association Study (GWAS) that revealed multiple single nucleotide polymorphism sites (SNPs) of the
FTO
gene, indicating an association between obesity and cancer in different populations. FTO proteins have been proved to participate in adipogenesis and tumorigenesis with post-transcriptional regulation of downstream molecular expression or through the target of the mammalian target protein rapamycin (mTOR). FTO inhibitors have also been found to share anti-obesity and anti-cancer effects
in vivo
. In this review, we comprehensively discuss the correlation between obesity and cancer by measuring
FTO
gene polymorphism, as well as the molecular mechanism involved in these diseases, emphasizing FTO as the common genetic basis of obesity and cancer.
Objective:
Our study aims to detect the sensitivity of the new biomarker miR-212 existing in serum
exosomes along with other hepatocellular carcinoma biomarkers such as AFP (alpha-fetoprotein), CA125 (carbohydrate
antigen-ca125), and Hbx protein in the diagnosis of HBV-related liver diseases. We also aim to study the roles
of these biomarkers in the progression of chronic hepatitis B and provide scientific data to show the clinical value of
these biomarkers.
Methods:
We selected 200 patients with HBV-infection (58 cases of chronic hepatitis B, 47 cases of hepatocellular
carcinoma, 30 cases of compensatory phase cirrhosis, and 65 cases of decompensatory phase cirrhosis), 31 patients
with primary liver cancer without HBV infection, and 70 healthy individuals as the control group. The expression
level of serum AFP and CA125 was detected with electrochemiluminescence immunoassay. The expression level of
the Hbx protein was detected with ELISA. Meanwhile, the expression level of miR-212 in serum was analyzed with
RT-qPCR. We collected patients’ clinical information following the Child-Pugh classification and MELD score
criterion, and statistical analysis was made between the expression level of miR-212 and the collected clinical indexes.
Lastly, we predicted the target genes of the miR-212 and its functions using bioinformatics methods such as
cluster analysis and survival prediction.
Results:
Compared to the control group, the expression level of miR-212 in HBV infected patients was remarkably
increased (P<0.05), especially between the HBV-infection Hepatocellular carcinoma group and the non-HBVinfection
liver cancer group (P<0.05). The expression of miR-212 was increased in patients’ Child-Pugh classification,
MELD score, and TNM staging. Moreover, the sensitivity and specificity of miR-212 were superior to AFP,
CA125, and HBx protein.
Conclusion:
There is a linear relationship between disease progression and expression level of miR-212 in the serum
of HBV infected patients. This demonstrates that miR-212 plays a significant role in liver diseases. miR-212 is expected
to be a new biomarker used for the diagnosis and assessment of patients with HBV-infection-related liver
diseases.
Background: To date, the pathogenesis of gastric cancer (GC) remains unclear. We combined public database resources and bioinformatics analysis methods, explored some novel genes and verified the experiments to further understand the pathogenesis of GC and to provide a promising target for anti-tumor therapy. Methods: We downloaded the chip data related to GC from the Gene Expression Omnibus (GEO) database, extracted differentially expressed genes (DEGs), and then determined the key genes in the development of GC via PPI networks and model analysis. Functional annotation via GO and KEGG enrichment of DEGs was used to understand the latent roles of DEGs. The expression of the triggering receptor expressed on myeloid cells 2 (TREM2) gene in GC cell lines was verified via RT-PCR and western blotting. Moreover, the CCK-8, wound healing assay, and transwell migration and invasion assays were used to understand the changes in the proliferation, migration, and invasion abilities of GC cells after silencing TREM2. Western blotting verified the interaction between TREM2 and PI3K predict of the string website, as well as the effect of TREM2 on EMT. Finally, a lung metastasis model was used to explore the relationship between TREM2 and metastasis. Results: Our study identified 16 key genes, namely BGN,
The long noncoding RNA (lncRNA) LINC00152, also known as CYTOR, displays aberrant expression in various cancers. However, its clinical value and functional mechanisms in breast cancer remain insufficiently understood. Our study found that LINC00152 is significantly upregulated in breast cancer, and that it acts as an indicator of poor survival prognosis. Further studies revealed that LINC00152 knockdown suppresses cell proliferation and tumorigenicity in vitro and in vivo. Mechanistic analyses demonstrated that LINC00152 directly binds to KLF5 protein and increases KLF5 stability. Moreover, LINC00152 is also a KLF5-responsive lncRNA, and KLF5 activates LINC00152 transcription by directly binding to its promoter. Our study suggests that LINC00152 promotes tumor progression by interacting with KLF5. LINC00152 may be a valuable prognostic predictor for breast cancer, and the positive feedback loop of LINC00152-KLF5 could be a therapeutic target in pharmacological strategies.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.